90Y-microsphere brachytherapy is effective in treating unresectable colorectal liver metastases

American Journal of Oncology Review

Volumn 5, Issue 10, 2006, Pages 609-613

  Kennedy, Andrew S ^a  

^a Wake Radiology Oncology   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE AMINOTRANSFERASE; ALKALINE PHOSPHATASE; AMMONIA; ASPARTATE AMINOTRANSFERASE; BEVACIZUMAB; BILIRUBIN; CAPECITABINE; CETUXIMAB; FLUOROURACIL; FOLINIC ACID; YTTRIUM 90;

ACUTE TOXICITY; ADVANCED CANCER; AGED; ARTIFICIAL EMBOLISM; BRACHYTHERAPY; CASE REPORT; COLORECTAL CARCINOMA; FATIGUE; FEVER; GASTROINTESTINAL TOXICITY; HUMAN; LIVER DYSFUNCTION; LIVER METASTASIS; MALE; NAUSEA; PAIN; REVIEW; STOMACH ULCER; TISSUE BLOOD FLOW; VOMITING; WEIGHT REDUCTION;

EID: 33845187820     PISSN: 15429520     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (17)

1. Jemal A, Murray T, Ward E, et al. Cancer statistics, 2005. CA Cancer J Clin. 2005;55:10-30.
2. Landis SH, Murray T, Bolden S, et al. Cancer statistics, 1999. CA Cancer J Clin. 1999;49:8-31.
3. Nagorney DM, Gigot JF. Primary epithelial hepatic malignancies: etiology, epidemiology, and outcome after subtotal and total hepatic resection. Surg Oncol Clin N Am. 1996;5:283-300.
4. Ellis LM, Curley SA, Tanabe KK. Radiofrequency ablation for cancer: current indications, techniques and outcomes. New York: Springer-Verlag; 2004.
5. Nag S, DeHaan M, Scruggs G, et al. Long-term follow-up of patients of intrahepatic malignancies treated with iodine-125 brachytherapy. Int J Radiat Oncol Biol Phys. 2006;64:736-744.
6. Ricke J, Wust P, Stohlmann A, et al. CT-guided interstitial brachytherapy of liver malignancies alone or in combination with thermal ablation: phase I-II results of a novel technique. Int J Radiat Oncol Biol Phys. 2004;58:1496-1505.
7. Kennedy AS, Coldwell D, Nutting C, et al. Resin 90Y-microsphere brachytherapy for unresectable colorectal liver metastases: modern USA experience. Int J Radiat Oncol Biol Phys. 2006;65:412-425.
8. Sato K, Lewandowski RJ, Bui JT, et al. Treatment of unresectable primary and metastatic liver cancer with yttrium-90 microspheres (TheraSphere): assessment of hepatic arterial embolization. Cardiovasc Intervent Radiol. 2006;29:522-529.
9. Campbell AM, Bailey IH, Burton MA. Analysis of the distribution of intra-arterial microspheres in human liver following hepatic yttrium-90 microsphere therapy. Phys Med Biol. 2000;45:1023-1033.
10. Fox RA, Klemp PF, Egan G, et al. Dose distribution following selective internal radiation therapy. Int J Radiat Oncol Biol Phys. 1991;21:463-467.
11. Kennedy AS, Nutting C, Coldwell D, et al. Pathologic response and microdosimetry of 90Y microspheres in man: review of four explanted whole livers. Int J Radiat Oncol Biol Phys. 2004;60:1552-1563.
12. Fajardo LF, Berthrong M, Anderson RE. Liver. In: Radiation Pathology. 1st ed. New York: Oxford University Press; 2001:249-257.
13. Fajardo LF, Colby TV. Pathogenesis of veno-occlusive liver disease after radiation. Arch Pathol Lab Med. 1980;104:584-588.
14. Gray B, Van Hazel G, Hope M, et al. Randomised trial of SIR-Spheres plus chemotherapy vs. chemotherapy alone for treating patients with liver metastases from primary large bowel cancer. Ann Oncol. 2001;12:1711-1720.
15. Van Hazel G, Blackwell A, Anderson J, et al. Randomised phase II trial of SIR-spheres plus fluorouracil/leucovrin chemotherapy versus fluororacil/leucovorin chemotherapy alone in advanced colorectal cancer. J Surg Oncol. 2004;88:78-85.
16. Van Hazel G, Pavlakis N, Goldstein D, et al. Selective internal radiation therapy (SIRT) plus systemic chemotherapy with irinotecan. A phase I dose escalation study. ASCO Gastrointestinal Cancers Symposium. 2005:223. Abstract.
17. Van Hazel G, Price D, Bower G, et al. Selective internal radiation therapy (SIRT) plus systemic chemotherapy with oxaliplatin, 5-fluorouracil and leucovorin: a phase I dose escalation study. ASCO Gastrointestinal Cancers Symposium. 2005:133. Abstract.